| Product Code: ETC10075762 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Hemophilia A Treatment Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Hemophilia A Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Hemophilia A Treatment Market - Industry Life Cycle |
3.4 Vietnam Hemophilia A Treatment Market - Porter's Five Forces |
3.5 Vietnam Hemophilia A Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Vietnam Hemophilia A Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Vietnam Hemophilia A Treatment Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Vietnam Hemophilia A Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Vietnam Hemophilia A Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Vietnam Hemophilia A Treatment Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
4 Vietnam Hemophilia A Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hemophilia A and its treatment options in Vietnam |
4.2.2 Growing healthcare infrastructure and facilities in the country |
4.2.3 Rising investments in research and development for hemophilia A therapies |
4.2.4 Supportive government initiatives and policies for rare disease management |
4.3 Market Restraints |
4.3.1 Limited access to advanced hemophilia A treatment options in remote areas of Vietnam |
4.3.2 High treatment costs associated with hemophilia A therapies |
4.3.3 Shortage of skilled healthcare professionals specializing in hemophilia A treatment in Vietnam |
4.3.4 Regulatory challenges and approval processes for new hemophilia A treatments in the market |
5 Vietnam Hemophilia A Treatment Market Trends |
6 Vietnam Hemophilia A Treatment Market, By Types |
6.1 Vietnam Hemophilia A Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Severe, 2021- 2031F |
6.1.4 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Moderate, 2021- 2031F |
6.1.5 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Mild, 2021- 2031F |
6.2 Vietnam Hemophilia A Treatment Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Recombinant Factor Concentrates, 2021- 2031F |
6.2.3 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Plasma-derived Factor Concentrates, 2021- 2031F |
6.2.4 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Extended Half-life Products, 2021- 2031F |
6.3 Vietnam Hemophilia A Treatment Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3.3 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Adult, 2021- 2031F |
6.4 Vietnam Hemophilia A Treatment Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.4.3 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Fibrinogen Test, 2021- 2031F |
6.4.4 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Factor VIII and Factor IX Tests, 2021- 2031F |
6.4.5 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Prothrombin Time (PT), 2021- 2031F |
6.4.6 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Complete Blood Count (CBC), 2021- 2031F |
6.5 Vietnam Hemophilia A Treatment Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.5.3 Vietnam Hemophilia A Treatment Market Revenues & Volume, By On Demand, 2021- 2031F |
6.6 Vietnam Hemophilia A Treatment Market, By Therapy |
6.6.1 Overview and Analysis |
6.6.2 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Factor Replacement Therapy, 2021- 2031F |
6.6.3 Vietnam Hemophilia A Treatment Market Revenues & Volume, By Non-factor Replacement Therapy, 2021- 2031F |
7 Vietnam Hemophilia A Treatment Market Import-Export Trade Statistics |
7.1 Vietnam Hemophilia A Treatment Market Export to Major Countries |
7.2 Vietnam Hemophilia A Treatment Market Imports from Major Countries |
8 Vietnam Hemophilia A Treatment Market Key Performance Indicators |
8.1 Number of hemophilia A patients diagnosed and under treatment in Vietnam |
8.2 Adoption rate of advanced hemophilia A treatment options in urban vs. rural areas |
8.3 Rate of successful outcomes and patient satisfaction with hemophilia A treatments |
8.4 Number of clinical trials and research studies conducted for hemophilia A therapies in Vietnam |
8.5 Patient adherence and compliance to prescribed hemophilia A treatment regimens |
9 Vietnam Hemophilia A Treatment Market - Opportunity Assessment |
9.1 Vietnam Hemophilia A Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Vietnam Hemophilia A Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Vietnam Hemophilia A Treatment Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Vietnam Hemophilia A Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 Vietnam Hemophilia A Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 Vietnam Hemophilia A Treatment Market Opportunity Assessment, By Therapy, 2021 & 2031F |
10 Vietnam Hemophilia A Treatment Market - Competitive Landscape |
10.1 Vietnam Hemophilia A Treatment Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Hemophilia A Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here